<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ACG Case Rep J</journal-id><journal-id journal-id-type="iso-abbrev">ACG Case Rep J</journal-id><journal-id journal-id-type="coden">ACGCRJ</journal-id><journal-id journal-id-type="publisher-id">AC9</journal-id><journal-title-group><journal-title>ACG Case Reports Journal</journal-title></journal-title-group><issn pub-type="epub">2326-3253</issn><publisher><publisher-name>Wolters Kluwer</publisher-name><publisher-loc>Maryland, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40401195</article-id><article-id pub-id-type="pmc">PMC12094328</article-id><article-id pub-id-type="publisher-id">ACGCR-24-0248</article-id><article-id pub-id-type="doi">10.14309/crj.0000000000001522</article-id><article-id pub-id-type="art-access-id">00012</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Liver</subject></subj-group></article-categories><title-group><article-title>Extrahepatic Intraductal Papillary Neoplasms of Bile Duct and Klatskin Tumor: Simultaneous Occurrence and Recurrence?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9728-6310</contrib-id><name><surname>Abuassi</surname><given-names>Mohammad</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Obed</surname><given-names>Mikal</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref><email>mikal.obed@stud.mh-hannover.de</email></contrib><contrib contrib-type="author"><name><surname>Dintner</surname><given-names>Sebastian</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">3</xref><email>Dintner@med.uni-goettingen.de</email></contrib><contrib contrib-type="author"><name><surname>F&#x000fc;zesi</surname><given-names>Laszlo</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">3</xref><email>fuezesi@med.uni-goettingen.de</email></contrib><contrib contrib-type="author"><name><surname>Siyam</surname><given-names>Mahmood</given-names></name><degrees>MD</degrees><xref rid="aff4" ref-type="aff">4</xref><email>M.siyam@hotmail.com</email></contrib><contrib contrib-type="author"><name><surname>Jarrad</surname><given-names>Anwar</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref><email>ajarrad@hotmail.com</email></contrib><contrib contrib-type="author"><name><surname>Obed</surname><given-names>Aiman</given-names></name><degrees>MD, PhD</degrees><xref rid="aff4" ref-type="aff">4</xref><email>aimanobed@hotmail.com</email></contrib><aff id="aff1"><label>1</label>Department of Internal Medicine, University of Central Florida, Gainesville, FL</aff><aff id="aff2"><label>2</label>Department of Hepatology, Gastroenterology and Hepatobiliary/Transplant, Jordan Hospital, Ibn Sina University for Medical Sciences, Amman, <country>Jordan</country></aff><aff id="aff3"><label>3</label>Department of Pathology, Faculty of Medicine, University of Augsburg, Augsburg, <country>Germany</country></aff><aff id="aff4"><label>4</label>Department of General Surgery, Jordan Hospital, Ibn Sina University for Medical Sciences, Amman, <country>Jordan</country></aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence:</bold> Mohammad Abuassi, MD (<email>abuassi1997@icloud.com</email>).</corresp></author-notes><pub-date pub-type="collection"><month>10</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>9</month><year>2024</year></pub-date><volume>11</volume><issue>10</issue><elocation-id>e01522</elocation-id><history><date date-type="received"><day>16</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>8</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="ac9-11-e01522.pdf"/><abstract><title>ABSTRACT</title><p>This case report presents a 64-year-old woman with unique occurrence and recurrence of 2 different neoplastic entities, extrahepatic intraductal papillary neoplasm of bile duct and Klatskin tumor (hilar cholangiocarcinoma or central bile duct carcinoma), found simultaneously in close proximity. To date, this coexistence and recurrence with long survival time has not been reported. The patient in this case is remarkable for both the combination of intraductal papillary neoplasm of bile duct and cholangiocarcinoma, confirmed with specimen from the first surgical intervention in 2005, and recurrence of both tumors after 15 years and the patient's extraordinary survival with histological proven liver cirrhosis Child-Pugh class A. This case highlights the possibility of simultaneous occurrence and late recurrence of different neoplasms in the bile duct system and calls attention to the need for consideration in atypical cases.</p></abstract><kwd-group><title>KEYWORDS:</title><kwd>cholangiocarcinoma</kwd><kwd>intraductal papillary neoplasm</kwd><kwd>Klatskin tumor</kwd><kwd>bile duct neoplasms</kwd><kwd>recurrence</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Cholangiocarcinoma (CC) and intraductal papillary neoplasm of the bile duct (IPNB) are rare and potentially malignant tumors that present significant diagnostic and therapeutic challenges.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> CC can be intrahepatic, hilar, or extrahepatic. The most common type is hilar, involving the common hepatic duct bifurcation, and is referred to as Klatskin tumor. Klatskin tumors are associated with complicated diagnostic procedures, and their anatomical location makes the surgical site less accessible, resulting in higher unresectable rates.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> On the other hand, IPNB is a preinvasive, intraductal growing tumor originating from the bile duct epithelium, consisting of papillary and villous structures, with potential for malignancy.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup> IPNB is classified as a biliary tumor subtype, according to the World Health Organization (WHO).<sup><xref rid="R6" ref-type="bibr">6</xref></sup></p><p>In this report, we present an exceptional case of a patient with 2 separate neoplastic entities, IPNB and Klatskin tumor, found in close proximity within the right bile duct and duct bifurcation, yet remarkable long-term survival of 19 years. To the best of our knowledge, this is the first reported case of the coexistence of these 2 distinct neoplasms with late recurrence. The case report highlights the need for careful evaluation and monitoring of patients with IPNB and the importance of considering the possibility of multiple neoplastic entities within the bile duct system.</p></sec><sec id="s2"><title>CASE REPORT</title><p>We report a case of a 64-year-old woman nonsmoker with history of hypertension, type 2 diabetes mellitus. The patient's surgical history includes splenectomy and metallic aortic valve replacement in 2011, as well as right hepatectomy with resection of the extrahepatic biliary system and left hepaticojejunostomy due to pathology proven combination of IPNB and intrahepatic CC in 2005, which was complicated postoperatively by portal vein thrombosis (Figure <xref rid="F1" ref-type="fig">1</xref>) that resolved after anticoagulation.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Postoperative computed tomography scan (2005) demonstrating portal vein thrombosis.</p></caption><graphic xlink:href="ac9-11-e01522-g001" position="float"/></fig><p>Initially, the follow-up course had been uneventful. But since 2017, regular insertion of a percutaneous transhepatic biliary drainage has been necessary every 3 months for recurrent cholangitis.</p><p>In early 2020, she was admitted via the emergency department due to severe fatigue, which occurred 1 month after the last percutaneous transhepatic biliary drainage. She reported experiencing nausea, nonbilious vomiting, and colicky abdominal pain in the right upper quadrant that was worsened with each meal. Biochemical testing revealed elevated inflammation parameters and liver enzymes, and her labs showed metabolic acidosis, hyponatremia, hyperkalemia associated with electrocardiographic changes (peaked T wave, flattened P wave, prolonged PR interval, and prolonged QRS duration), and acute kidney injury (Table <xref rid="T1" ref-type="table">1</xref>). Overall findings were consistent with acute cholangitis, and percutaneous transhepatic cholangiography was placed to drain infection. Abdominal magnetic resonance cholangiopancreatography revealed moderate intrahepatic biliary dilation of the left hepatic duct with heterogeneous signal intensity and free contrast media flow in the biliary tree and jejunal loop, with no evidence of free peritoneal leakage. Based on these imaging findings, we suspected postsurgical fibrotic changes of the bile duct rather than recurrence of the Klatskin tumor.</p><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p>Laboratory results upon patient's admission on February 26, 2020</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">Test (abbreviation)</td><td rowspan="1" colspan="1">Patient</td><td rowspan="1" colspan="1">Normal range</td><td rowspan="1" colspan="1">Units</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Hemoglobin (HB)</td><td align="char" char="." rowspan="1" colspan="1">10.9</td><td rowspan="1" colspan="1">12&#x02013;15.5 (female)</td><td rowspan="1" colspan="1">g/dL</td></tr><tr><td rowspan="1" colspan="1">White blood cell count (WBC)</td><td align="char" char="." rowspan="1" colspan="1">9.41</td><td rowspan="1" colspan="1">4&#x02013;11 &#x000d7; 10^3</td><td rowspan="1" colspan="1">cells/&#x000b5;L</td></tr><tr><td rowspan="1" colspan="1">Platelets (PLT)</td><td align="char" char="." rowspan="1" colspan="1">460</td><td rowspan="1" colspan="1">150&#x02013;400 &#x000d7; 10<sup>3</sup></td><td rowspan="1" colspan="1">cells/&#x000b5;L</td></tr><tr><td rowspan="1" colspan="1">Bicarbonate (HCO3)</td><td align="char" char="." rowspan="1" colspan="1">8.6</td><td rowspan="1" colspan="1">22&#x02013;26</td><td rowspan="1" colspan="1">mmol/L</td></tr><tr><td rowspan="1" colspan="1">Chloride (Cl)</td><td align="char" char="." rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">96&#x02013;106</td><td rowspan="1" colspan="1">mmol/L</td></tr><tr><td rowspan="1" colspan="1">Phosphorus (P)</td><td align="char" char="." rowspan="1" colspan="1">6.1</td><td rowspan="1" colspan="1">2.5&#x02013;4.5</td><td rowspan="1" colspan="1">mg/dL</td></tr><tr><td rowspan="1" colspan="1">Creatinine (Cr)</td><td align="char" char="." rowspan="1" colspan="1">1.75</td><td rowspan="1" colspan="1">0.7&#x02013;1.2</td><td rowspan="1" colspan="1">mg/dL</td></tr><tr><td rowspan="1" colspan="1">Sodium (Na)</td><td align="char" char="." rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">135&#x02013;145</td><td rowspan="1" colspan="1">mmol/L</td></tr><tr><td rowspan="1" colspan="1">Urea (BUN)</td><td align="char" char="." rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">7&#x02013;20</td><td rowspan="1" colspan="1">mg/dL</td></tr><tr><td rowspan="1" colspan="1">Potassium (K)</td><td align="char" char="." rowspan="1" colspan="1">7.03</td><td rowspan="1" colspan="1">3.5&#x02013;5.0</td><td rowspan="1" colspan="1">mmol/L</td></tr><tr><td rowspan="1" colspan="1">Calcium (Ca)</td><td align="char" char="." rowspan="1" colspan="1">10.74</td><td rowspan="1" colspan="1">8.5&#x02013;10.5</td><td rowspan="1" colspan="1">mg/dL</td></tr><tr><td rowspan="1" colspan="1">Amylase</td><td align="char" char="." rowspan="1" colspan="1">189</td><td rowspan="1" colspan="1">30&#x02013;110</td><td rowspan="1" colspan="1">U/L</td></tr><tr><td rowspan="1" colspan="1">Lipase</td><td align="char" char="." rowspan="1" colspan="1">400</td><td rowspan="1" colspan="1">13&#x02013;60</td><td rowspan="1" colspan="1">U/L</td></tr><tr><td rowspan="1" colspan="1">Partial thromboplastin time (PTT)</td><td align="char" char="." rowspan="1" colspan="1">44.4</td><td rowspan="1" colspan="1">25&#x02013;35</td><td rowspan="1" colspan="1">Seconds</td></tr><tr><td rowspan="1" colspan="1">Prothrombin time (PT)</td><td align="char" char="." rowspan="1" colspan="1">35.5</td><td rowspan="1" colspan="1">11&#x02013;13.5</td><td rowspan="1" colspan="1">Seconds</td></tr><tr><td rowspan="1" colspan="1">International normalized ratio (INR)</td><td align="char" char="." rowspan="1" colspan="1">2.84</td><td rowspan="1" colspan="1">0.8&#x02013;1.2</td><td rowspan="1" colspan="1">&#x02014;</td></tr><tr><td rowspan="1" colspan="1">Alanine aminotransferase (ALT)</td><td align="char" char="." rowspan="1" colspan="1">34.7</td><td rowspan="1" colspan="1">7&#x02013;56</td><td rowspan="1" colspan="1">U/L</td></tr><tr><td rowspan="1" colspan="1">Aspartate aminotransferase (AST)</td><td align="char" char="." rowspan="1" colspan="1">52.3</td><td rowspan="1" colspan="1">10&#x02013;40</td><td rowspan="1" colspan="1">U/L</td></tr><tr><td rowspan="1" colspan="1">Albumin</td><td align="char" char="." rowspan="1" colspan="1">4.32</td><td rowspan="1" colspan="1">3.5&#x02013;5.5</td><td rowspan="1" colspan="1">g/dL</td></tr><tr><td rowspan="1" colspan="1">Total protein (TP)</td><td align="char" char="." rowspan="1" colspan="1">8.5</td><td rowspan="1" colspan="1">6.0&#x02013;8.3</td><td rowspan="1" colspan="1">g/dL</td></tr><tr><td rowspan="1" colspan="1">Total bilirubin (TBIL)</td><td align="char" char="." rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.3&#x02013;1.2</td><td rowspan="1" colspan="1">mg/dL</td></tr><tr><td rowspan="1" colspan="1">Direct bilirubin (DBIL)</td><td align="char" char="." rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0&#x02013;0.3</td><td rowspan="1" colspan="1">mg/dL</td></tr><tr><td rowspan="1" colspan="1">Gamma glutamyl transferase (GGT)</td><td align="char" char="." rowspan="1" colspan="1">705</td><td rowspan="1" colspan="1">9&#x02013;48</td><td rowspan="1" colspan="1">U/L</td></tr><tr><td rowspan="1" colspan="1">Alkaline phosphatase (ALP)</td><td align="char" char="." rowspan="1" colspan="1">482</td><td rowspan="1" colspan="1">44&#x02013;147</td><td rowspan="1" colspan="1">U/L</td></tr><tr><td rowspan="1" colspan="1">pH</td><td align="char" char="." rowspan="1" colspan="1">7.2</td><td rowspan="1" colspan="1">7.35&#x02013;7.45</td><td rowspan="1" colspan="1">&#x02014;</td></tr><tr><td rowspan="1" colspan="1">Partial pressure of oxygen (PaO2)</td><td align="char" char="." rowspan="1" colspan="1">125.2</td><td rowspan="1" colspan="1">75&#x02013;100</td><td rowspan="1" colspan="1">mm Hg</td></tr><tr><td rowspan="1" colspan="1">Partial pressure of carbon dioxide (PaCO2)</td><td align="char" char="." rowspan="1" colspan="1">22.6</td><td rowspan="1" colspan="1">35&#x02013;45</td><td rowspan="1" colspan="1">mm Hg</td></tr></tbody></table></table-wrap><p>One month later, we performed a redo hepaticojejunostomy. Intraoperatively, it took at least 4 hours to reach the anastomosis site due to severe adhesions. Collaterals around the cirrhotic liver were also observed, indicating the presence of portal hypertension. After complete mobilization of the hepaticojejunostomy, we observed intraluminal masses in the small bowel loop of the hepaticojejunostomy, which displayed a paved quality that could be lifted off the jejunal mucous membrane. A new hepaticojejunostomy was performed, and 50 cm of the small bowel was resected (Figures <xref rid="F2" ref-type="fig">2</xref> and <xref rid="F3" ref-type="fig">3</xref>). Samples were sent for final histopathological examination and showed irregular and bulky, with a gleaming gray/whitish surface on macroscopic examination, confirming IPNB and intrahepatic CC recurrence (Figure <xref rid="F4" ref-type="fig">4</xref>). Papillary tumor cells of IPNB respected the biliary duct wall. On the other hand, perihilar CC (pCC) was poorly differentiated and showed a spatial distance to IPNB. The remaining liver showed no focal lesions, but a coarse surface quality suggested chronic liver disease. Further molecular analysis of the new and old samples from the patient was carried out after passing internal Next-Generation Sequencing testing quality control. Two pathogenic single nucleotide variants in the FGFR2 (NM_022970.3) gene and a copy number gain of the MYC transcription factor were identified in all 3 specimens (Table <xref rid="T2" ref-type="table">2</xref>).</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>(A) Preoperative cholangiogram depicting filling defect and intrahepatic ducts; (B) computed tomography scan revealing splenomegaly and prominent venous collaterals.</p></caption><graphic xlink:href="ac9-11-e01522-g002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p>(A) Postoperative cholangiogram displaying absence of filling defect and intrahepatic ducts; (B) computed tomography scan illustrating patent portal vein and cirrhotic remnant in left liver lobe.</p></caption><graphic xlink:href="ac9-11-e01522-g003" position="float"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><p>Co-occurrence of intraductal papillary neoplasm of the biliary tract (lower left section) and poorly differentiated cholangiocarcinoma (upper left section and the upper and lower right sections).</p></caption><graphic xlink:href="ac9-11-e01522-g004" position="float"/></fig><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p>Patient's tumor characteristics and genetic alterations</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Location</td><td rowspan="1" colspan="1">Age at diagnosis</td><td rowspan="1" colspan="1">Mutation (variant allele frequency)</td><td rowspan="1" colspan="1">Copy number variation, copy number</td></tr></thead><tbody><tr><td rowspan="2" colspan="1">1</td><td rowspan="2" colspan="1">Right bile duct</td><td align="char" char="." rowspan="2" colspan="1">48</td><td rowspan="1" colspan="1">FGFR2, c.1147T&#x0003e;C, p.Cys383Arg (65)</td><td rowspan="2" colspan="1">MYC, 5</td></tr><tr><td rowspan="1" colspan="1">FGFR2, c.1159T&#x0003e;G, p.Phe387Val (65)</td></tr><tr><td rowspan="2" colspan="1">2</td><td rowspan="2" colspan="1">Left bile duct</td><td align="char" char="." rowspan="2" colspan="1">64</td><td rowspan="1" colspan="1">FGFR2, c.1147T&#x0003e;C, p.Cys383Arg (34)</td><td rowspan="2" colspan="1">MYC, 5</td></tr><tr><td rowspan="1" colspan="1">FGFR2, c.1159T&#x0003e;G, p.Phe387Val (34)</td></tr><tr><td rowspan="2" colspan="1">3</td><td rowspan="2" colspan="1">Small intestine</td><td align="char" char="." rowspan="2" colspan="1">64</td><td rowspan="1" colspan="1">FGFR2, c.1147T&#x0003e;C, p.Cys383Arg (57)</td><td rowspan="2" colspan="1">MYC, 5</td></tr><tr><td rowspan="1" colspan="1">FGFR2, c.1159T&#x0003e;G, p.Phe387Val (56)</td></tr></tbody></table></table-wrap><p>Postoperative tests showed no signs of biliary obstruction, and the patient's recovery was uneventful. The patient has since shown up regularly for follow-up examinations and has been in good general condition.</p></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>CC is a highly aggressive malignant tumor that commonly affects the biliary tract.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> It is often categorized as intrahepatic or extrahepatic, with the latter further divided into hilar/perihilar (Klatskin tumor) and distal subtypes. Among these, extrahepatic CCs are the most prevalent. A specific subtype of extrahepatic CC, pCC, is located in the extrahepatic biliary tree proximal to the cystic duct's origin. Due to its complicated diagnostic pathway and anatomical location, pCC is associated with higher rates of unrespectability.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Notably, pCC accounts for approximately 50% of CC, followed by distal (40%), and intrahepatic ones (&#x0003c;10%).<sup><xref rid="R8" ref-type="bibr">8</xref></sup></p><p>The etiology of CC is mainly linked to infections, including infections with the liver flukes <italic toggle="yes">Clonorchis sinensis</italic> (<italic toggle="yes">C. sinensis</italic>) and <italic toggle="yes">Opisthorchis viverrini</italic>.<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> In addition, chronic infection with hepatitis B and C viruses (hepatitis B virus and hepatitis C virus) may also be associated with CC.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup> In our patient, 2 pathogenic single nucleotide variants in the FGFR2 gene and a copy number gain of the MYC transcription factor were identified in all 3 specimens. This indicates that the cancer development in this patient is likely driven by these inherited or acquired genetic mutations, rather than the more commonly associated infectious causes such as liver fluke infections or chronic hepatitis B and C virus infections. Klatskin tumor is a rare type of tumor that arises from the bifurcation of the extrahepatic bile duct and is also known as hilar CC or central bile duct carcinoma (Klatskin tumor). It accounts for only 1 in 100,000 annual incidences and typically presents with fatigue, jaundice, and cachexia, indicating metastatic or advanced tumors.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> Most patients with Klatskin tumors present with biliary symptoms, primarily painless jaundice, and less frequently with cholangitis if no previous biliary intervention has been performed. However, cholangitis becomes more common after biliary intervention, as observed in our case during the patient's second presentation.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> Klatskin tumors are a subtype of extrahepatic CC and pose a diagnostic challenge due to the difficulties associated with their classification.<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup></p><p>IPNB is a rare, preinvasive, and potentially malignant tumor of the bile duct that presents significant diagnostic and therapeutic challenges. The latest edition of the WHO Classification of Digestive System Tumors (2019) defines IPNB as a tumor originating from the bile epithelium, consisting of papillary and villous structures.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Before its inclusion in the 2010 WHO classification, various types of tumors were included in the IPNB group, such as papilloma/ductal papilloma, intraductal bile duct carcinomas, papillary carcinomas of the extrahepatic bile duct, cystadenomas, and biliary cystadenomas.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Currently, IPNB includes only intraductal growing bile carcinomas and papillary carcinomas of the extrahepatic bile ducts that grow intraductally in the form of papillary structures.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> IPNB has been observed to recur in the bile duct after surgical resection. Despite negative testing of the initial resection stump of the bile duct, the recurrent intraductal papillary tumor presents with tissue image similar to the initial resection, resembling the characteristics of intraductal papillary mucinous neoplasm. In some cases, IPNB recurs after more than 10 years, appearing as new carcinoma, suggesting multicentric growth of intraductal papillary mucinous neoplasm.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Therefore, a careful observation of the clinical course is necessary, with postoperative intraductal recurrence in mind. These findings highlight the need for continued surveillance of patients after surgical resection for IPNB to ensure early detection and prompt management of any recurrence.</p><p>The unique simultaneous occurrence and late recurrence in our case of 2 separate neoplastic entities, IPNB and Klatskin tumor, that were found in close proximity within the right bile duct and duct bifurcation have not been reported in literature before. The patient underwent right hepatectomy, bile duct resection, and hepaticojejunostomy with the left bile duct in 2005. In 2020, a surgical redo of the hepaticojejunostomy was required due to recurrent cholangitis and a narrowed anastomosis with an unclear cause.</p><p>In conclusion, this case underscores the effectiveness of surgical intervention in achieving optimal survival rates even in cases of simultaneous occurrence and late recurrence of distinct neoplasms within the bile duct system. It is of vital importance to report all cases of this nature to enable better characterization and optimization of patient outcomes.</p></sec><sec id="s4"><title>DISCLOSURES</title><p>Author contributions: M. Abuassi and M. Obed: Main Manuscript writing and data organization; M. Siyam: data collection from Jordan Hospital and Hadassah Medical Center; L. Fuzesi: reviewed and wrote the pathology section and slides; S. Dintner: performed and wrote the molecular and genetics sections of the paper; A. Jarrad and A. Obed: performed procedures and surgery, provided care and follow-up for the patient, final review of the manuscript. M. Abuassi is the article guarantor.</p><p>Financial disclosure: None to report.</p><p>Informed consent was obtained for this case report.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>SY</given-names></name>
<name><surname>Kim</surname><given-names>DU</given-names></name>
<name><surname>Nam</surname><given-names>HS</given-names></name>
<etal/></person-group>
<article-title>Comparison of the malignant predictors in intrahepatic and extrahepatic intraductal papillary neoplasm of the bile duct</article-title>. <source>J Clin Med.</source>
<year>2022</year>;<volume>11</volume>(<issue>7</issue>):<fpage>1985</fpage>.<pub-id pub-id-type="pmid">35407592</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Liu</surname><given-names>H</given-names></name></person-group>. <article-title>Klatskin tumor: A population-based study of incidence and survival</article-title>. <source>Med Sci Monit.</source>
<year>2019</year>;<volume>25</volume>:<fpage>4503</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">31204730</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dondossola</surname><given-names>D</given-names></name>
<name><surname>Ghidini</surname><given-names>M</given-names></name>
<name><surname>Grossi</surname><given-names>F</given-names></name>
<name><surname>Rossi</surname><given-names>G</given-names></name>
<name><surname>Foschi</surname><given-names>D</given-names></name></person-group>. <article-title>Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma</article-title>. <source>World J Gastroenterol.</source>
<year>2020</year>;<volume>26</volume>(<issue>25</issue>):<fpage>3542</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">32742125</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawczyk</surname><given-names>M</given-names></name>
<name><surname>Ziarkiewicz-Wr&#x000f3;blewska</surname><given-names>B</given-names></name>
<name><surname>Podg&#x000f3;rska</surname><given-names>J</given-names></name>
<etal/></person-group>
<article-title>Intraductal papillary neoplasm of the bile duct - A comprehensive review</article-title>. <source>Adv Med Sci.</source>
<year>2021</year>;<volume>66</volume>(<issue>1</issue>):<fpage>138</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">33556909</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>Y</given-names></name>
<name><surname>Ohtsuka</surname><given-names>M</given-names></name>
<name><surname>Sugiyama</surname><given-names>H</given-names></name>
<etal/></person-group>
<article-title>Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct</article-title>. <source>World J Gastroenterol.</source>
<year>2021</year>;<volume>27</volume>(<issue>15</issue>):<fpage>1569</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">33958844</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>XS</given-names></name>
<name><surname>Xu</surname><given-names>YY</given-names></name>
<name><surname>Qian</surname><given-names>JY</given-names></name>
<etal/></person-group>
<article-title>Intraductal papillary neoplasm of the bile duct</article-title>. <source>World J Gastroenterol.</source>
<year>2013</year>;<volume>19</volume>(<issue>46</issue>):<fpage>8595</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">24379576</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name>
<name><surname>Yadav</surname><given-names>S</given-names></name></person-group>. <article-title>Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors</article-title>. <source>Ann Gastroenterol.</source>
<year>2018</year>;<volume>31</volume>(<issue>2</issue>):<fpage>231</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">29507471</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeOliveira</surname><given-names>ML</given-names></name>
<name><surname>Cunningham</surname><given-names>SC</given-names></name>
<name><surname>Cameron</surname><given-names>JL</given-names></name>
<etal/></person-group>
<article-title>Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution</article-title>. <source>Ann Surg.</source>
<year>2007</year>;<volume>245</volume>(<issue>5</issue>):<fpage>755</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">17457168</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>MK</given-names></name>
<name><surname>Ju</surname><given-names>YH</given-names></name>
<name><surname>Franceschi</surname><given-names>S</given-names></name>
<etal/></person-group>
<article-title><italic toggle="yes">Clonorchis sinensis</italic> infection and increasing risk of cholangiocarcinoma in the Republic of Korea</article-title>. <source>Am J Trop Med Hyg.</source>
<year>2006</year>;<volume>75</volume>(<issue>1</issue>):<fpage>93</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">16837714</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurathong</surname><given-names>S</given-names></name>
<name><surname>Lerdverasirikul</surname><given-names>P</given-names></name>
<name><surname>Wongpaitoon</surname><given-names>V</given-names></name>
<etal/></person-group>
<article-title><italic toggle="yes">Opisthorchis viverrini</italic> infection and cholangiocarcinoma. A prospective, case-controlled study</article-title>. <source>Gastroenterology.</source>
<year>1985</year>;<volume>89</volume>(<issue>1</issue>):<fpage>151</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">2989071</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouvard</surname><given-names>V</given-names></name>
<name><surname>Baan</surname><given-names>R</given-names></name>
<name><surname>Straif</surname><given-names>K</given-names></name>
<etal/></person-group>
<article-title>A review of human carcinogens--Part B: Biological agents</article-title>. <source>Lancet Oncol.</source>
<year>2009</year>;<volume>10</volume>(<issue>4</issue>):<fpage>321</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">19350698</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>HR</given-names></name>
<name><surname>Oh</surname><given-names>JK</given-names></name>
<name><surname>Masuyer</surname><given-names>E</given-names></name>
<etal/></person-group>
<article-title>Epidemiology of cholangiocarcinoma: An update focusing on risk factors</article-title>. <source>Cancer Sci.</source>
<year>2010</year>;<volume>101</volume>(<issue>3</issue>):<fpage>579</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">20085587</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seehofer</surname><given-names>D</given-names></name>
<name><surname>Kamphues</surname><given-names>C</given-names></name>
<name><surname>Neuhaus</surname><given-names>P</given-names></name></person-group>. <article-title>[Resection of Klatskin tumors]</article-title>. <source>Der Chirurg.</source>
<year>2012</year>;<volume>83</volume>(<issue>3</issue>):<fpage>221</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarnagin</surname><given-names>W</given-names></name>
<name><surname>Winston</surname><given-names>C</given-names></name></person-group>. <article-title>Hilar cholangiocarcinoma: Diagnosis and staging</article-title>. <source>HPB.</source>
<year>2005</year>;<volume>7</volume>(<issue>4</issue>):<fpage>244</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">18333200</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>MJ</given-names></name>
<name><surname>Lim</surname><given-names>J</given-names></name>
<name><surname>Han</surname><given-names>SS</given-names></name>
<etal/></person-group>
<article-title>Impact of changes in the topographic classification of Klatskin tumor on incidence of intra- and extrahepatic bile duct cancer: A population-based national cancer registry study</article-title>. <source>J Hepatobiliary Pancreat Sci.</source>
<year>2021</year>;<volume>28</volume>(<issue>9</issue>):<fpage>740</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">33615747</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>K</given-names></name>
<name><surname>Rocha</surname><given-names>FG</given-names></name>
<name><surname>Ito</surname><given-names>K</given-names></name>
<etal/></person-group>
<article-title>The Blumgart preoperative staging system for hilar cholangiocarcinoma: Analysis of resectability and outcomes in 380 patients</article-title>. <source>J Am Coll Surg.</source>
<year>2012</year>;<volume>215</volume>(<issue>3</issue>):<fpage>343</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">22749003</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bosman</surname><given-names>FT</given-names></name>
<name><surname>Carneiro</surname><given-names>F</given-names></name>
<name><surname>Hruban</surname><given-names>RH</given-names></name>
<name><surname>Theise</surname><given-names>ND</given-names></name></person-group>. <article-title>WHO classification of tumours of the digestive system</article-title>. <source>WHO Classification of Tumours of the Digestive System</source> (<year>2010</year>);(Ed. 4) (<ext-link xlink:href="https://www.cabdirect.org/cabdirect/abstract/20113051318" ext-link-type="uri">https://www.cabdirect.org/cabdirect/abstract/20113051318</ext-link>). Accessed February 27, 2023.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanuma</surname><given-names>Y</given-names></name>
<name><surname>Sugino</surname><given-names>T</given-names></name>
<name><surname>Kakuda</surname><given-names>Y</given-names></name>
<etal/></person-group>
<article-title>Pathologic patterns of invasive carcinoma associated with intraductal papillary neoplasms of bile duct (IPNB)</article-title>. <source>Ann Diagn Pathol.</source>
<year>2022</year>;<volume>61</volume>:<fpage>152055</fpage>.<pub-id pub-id-type="pmid">36279801</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>Y</given-names></name>
<name><surname>Kondo</surname><given-names>S</given-names></name>
<name><surname>Hirano</surname><given-names>S</given-names></name>
<etal/></person-group>
<article-title>Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation</article-title>. <source>J Hepatobiliary Pancreat Surg.</source>
<year>2006</year>;<volume>13</volume>(<issue>4</issue>):<fpage>355</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16858550</pub-id>
</mixed-citation></ref></ref-list></back></article>